Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.

Tricou, Vianney; Winkle, Peter J; Tharenos, Leslie M; Rauscher, Martina; Escudero, Ian; Hoffman, Elaine; LeFevre, Inge; Borkowski, Astrid; Wallace, Derek

Tricou, Vianney; Winkle, Peter J; Tharenos, Leslie M; Rauscher, Martina; Escudero, Ian; Hoffman, Elaine; LeFevre, Inge; Borkowski, Astrid; Wallace, Derek.

Afiliación

Tricou V; Takeda Pharmaceuticals International, Zurich, Switzerland. Electronic address: vianney.tricou@takeda.com.
Winkle PJ; Anaheim Clinical Trials, Anaheim, CA, USA.
Tharenos LM; Synexus - St. Louis, St. Louis, MO, USA.
Rauscher M; Takeda Pharmaceuticals International, Zurich, Switzerland.
Escudero I; Takeda Vaccines, Singapore.
Hoffman E; Takeda Vaccines, Cambridge, MA, USA.
LeFevre I; Takeda Pharmaceuticals International, Zurich, Switzerland.
Borkowski A; Takeda Pharmaceuticals International, Zurich, Switzerland.
Wallace D; Takeda Vaccines, Cambridge, MA, USA.

Vaccine ; 41(47): 6999-7006, 2023 11 13.

Article en En | MEDLINE | ID: mdl-37884415

Asunto(s)

Vacunas contra el Dengue; Dengue; Humanos; Adulto; Dengue/prevención & control; Vacunas Combinadas; Vacunación/métodos; Método Doble Ciego; Inmunogenicidad Vacunal; Anticuerpos Antivirales; Anticuerpos Neutralizantes

Palabras clave

Dengue virus; Immunogenicity; Reactogenicity; Safety; Tetravalent; Vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dengue / Vacunas contra el Dengue Límite: Adult / Humans Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google